Indication

Percutaneous Coronary Intervention

1 clinical trial

1 drug

Clinical trial
Cardio-protective Effect of Metformin in Patients Undergoing Elective Percutaneous Coronary Intervention
Status: Active (not recruiting), Estimated PCD: 2021-12-09